特殊审批程序的沟通交流要点剖析

Analysis of the Key Points of Communication and Exchange in Special Approval Procedure

在与国内企业的讨论当中,经常会碰到纠缠于临床试验的最低病例数讨价还价的情况,这种讨论是糟糕的,甚至失去了沟通交流的意义。需要建立一种有效的交流机制,明确各自的责任。

In the discussion with domestic pharmaceutical companies, haggling about the minimal number of cases is frequently seen.The author thought that such discussion is ineffective.It is necessary to set up an effective system for communication and exchange with clear respective responsibilities.